Sono-Tek (SOTK) Q2 2027 earnings summary

Executive summary

• H1 FY27 net sales rose 6% to $10.893M, gross margin expanded to 55%, operating income increased 41% to $1.279M and net income rose 22% to $1.107M, led by medical demand.

• Q2 sales increased 1% to $5.232M; operating income fell 9% to $382K and net income declined to $366K as higher expenses offset gross-profit growth.

• FY27 revenue guidance remained flat to modest growth; $7.19M in post-quarter Advanced Energy orders are expected to ship primarily in FY28.

Financial highlights

• Q2 net sales were $5.232M versus $5.163M; gross profit rose to $2.767M from $2.590M, while operating expenses increased 10% to $2.385M.

• Q2 operating income was $382K, down 9%; net income was $366K, down 14%, and diluted EPS was $0.02 versus $0.03.

• H1 net sales were $10.893M versus $10.295M; gross profit rose to $5.981M from $5.254M, operating income to $1.279M from $905K, and net income to $1.107M from $909K.

• H1 diluted EPS was $0.07 versus $0.06; R&D expense was steady, while selling, marketing and G&A expenses increased.

Outlook and guidance

• FY27 revenue guidance was reiterated at flat to modest growth, with large, higher-value production-system order timing driving quarter-to-quarter variability.

• Most of the $7.19M Advanced Energy order is expected to ship in FY28; management expects the orders to lift reported FY28 sales amid continued sector weakness.

• Marketing and sales expenses are expected to rise in H2 FY27 as investment increases in sales, forward-deployed engineering and programming personnel.

• Semiconductor opportunities may produce initial machines within a year, but significant production-scale impact could take one to three years and depends on customer validation.